Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050

Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A. H.Jan Danser, Piet M. Ter Wee, Michaela Diamant, Jaap A. Joles, Daniel H. van Raalte

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Number of pages1
JournalDiabetes Care
Volume42
Issue number3
DOIs
Publication statusPublished - 1 Mar 2019

Cite this

@article{c777fcd2e2254ae8b6978a6c18ae6d5a,
title = "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050",
author = "Lennart Tonneijck and Smits, {Mark M.} and Muskiet, {Marcel H.A.} and Trynke Hoekstra and Kramer, {Mark H.H.} and Danser, {A. H.Jan} and {Ter Wee}, {Piet M.} and Michaela Diamant and Joles, {Jaap A.} and {van Raalte}, {Daniel H.}",
year = "2019",
month = "3",
day = "1",
doi = "10.2337/dc19-er03",
language = "English",
volume = "42",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes

T2 - A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050

AU - Tonneijck, Lennart

AU - Smits, Mark M.

AU - Muskiet, Marcel H.A.

AU - Hoekstra, Trynke

AU - Kramer, Mark H.H.

AU - Danser, A. H.Jan

AU - Ter Wee, Piet M.

AU - Diamant, Michaela

AU - Joles, Jaap A.

AU - van Raalte, Daniel H.

PY - 2019/3/1

Y1 - 2019/3/1

UR - http://www.scopus.com/inward/record.url?scp=85061964671&partnerID=8YFLogxK

U2 - 10.2337/dc19-er03

DO - 10.2337/dc19-er03

M3 - Comment/Letter to the editor

VL - 42

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 3

ER -